133 related articles for article (PubMed ID: 30885937)
1. PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma.
Smith HG; Mansfield D; Roulstone V; Kyula-Currie JN; McLaughlin M; Patel RR; Bergerhoff KF; Paget JT; Dillon MT; Khan A; Melcher A; Thway K; Harrington KJ; Hayes AJ
Clin Cancer Res; 2019 Jun; 25(11):3443-3454. PubMed ID: 30885937
[TBL] [Abstract][Full Text] [Related]
2. Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma.
Pencavel TD; Wilkinson MJ; Mansfield DC; Khan AA; Seth R; Karapanagiotou EM; Roulstone V; Aguilar RJ; Chen NG; Szalay AA; Hayes AJ; Harrington KJ
Int J Cancer; 2015 Feb; 136(4):965-76. PubMed ID: 24978211
[TBL] [Abstract][Full Text] [Related]
3. Isolated limb perfusion with biochemotherapy and oncolytic virotherapy combines with radiotherapy and surgery to overcome treatment resistance in an animal model of extremity soft tissue sarcoma.
Wilkinson MJ; Smith HG; Pencavel TD; Mansfield DC; Kyula-Currie J; Khan AA; McEntee G; Roulstone V; Hayes AJ; Harrington KJ
Int J Cancer; 2016 Sep; 139(6):1414-22. PubMed ID: 27116656
[TBL] [Abstract][Full Text] [Related]
4. Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade.
Chon HJ; Lee WS; Yang H; Kong SJ; Lee NK; Moon ES; Choi J; Han EC; Kim JH; Ahn JB; Kim JH; Kim C
Clin Cancer Res; 2019 Mar; 25(5):1612-1623. PubMed ID: 30538109
[TBL] [Abstract][Full Text] [Related]
5. Effective oncolytic vaccinia therapy for human sarcomas.
He S; Li P; Chen CH; Bakst RL; Chernichenko N; Yu YA; Chen N; Szalay AA; Yu Z; Fong Y; Wong RJ
J Surg Res; 2012 Jun; 175(2):e53-60. PubMed ID: 22341347
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.
Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA
J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320
[TBL] [Abstract][Full Text] [Related]
7. Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 Antibody.
Kanaya N; Kuroda S; Kakiuchi Y; Kumon K; Tsumura T; Hashimoto M; Morihiro T; Kubota T; Aoyama K; Kikuchi S; Nishizaki M; Kagawa S; Tazawa H; Mizuguchi H; Urata Y; Fujiwara T
Mol Ther; 2020 Mar; 28(3):794-804. PubMed ID: 31991110
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma.
Gentschev I; Adelfinger M; Josupeit R; Rudolph S; Ehrig K; Donat U; Weibel S; Chen NG; Yu YA; Zhang Q; Heisig M; Thamm D; Stritzker J; Macneill A; Szalay AA
PLoS One; 2012; 7(5):e37239. PubMed ID: 22615950
[TBL] [Abstract][Full Text] [Related]
9. Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68.
Gentschev I; Donat U; Hofmann E; Weibel S; Adelfinger M; Raab V; Heisig M; Chen N; Yu YA; Stritzker J; Szalay AA
J Biomed Biotechnol; 2010; 2010():489759. PubMed ID: 20379368
[TBL] [Abstract][Full Text] [Related]
10. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68.
Gentschev I; Müller M; Adelfinger M; Weibel S; Grummt F; Zimmermann M; Bitzer M; Heisig M; Zhang Q; Yu YA; Chen NG; Stritzker J; Lauer UM; Szalay AA
PLoS One; 2011; 6(7):e22069. PubMed ID: 21779374
[TBL] [Abstract][Full Text] [Related]
11. Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40.
Messenheimer DJ; Jensen SM; Afentoulis ME; Wegmann KW; Feng Z; Friedman DJ; Gough MJ; Urba WJ; Fox BA
Clin Cancer Res; 2017 Oct; 23(20):6165-6177. PubMed ID: 28855348
[No Abstract] [Full Text] [Related]
12. Oncolytic vaccinia virus combined with radiotherapy induces apoptotic cell death in sarcoma cells by down-regulating the inhibitors of apoptosis.
Wilkinson MJ; Smith HG; McEntee G; Kyula-Currie J; Pencavel TD; Mansfield DC; Khan AA; Roulstone V; Hayes AJ; Harrington KJ
Oncotarget; 2016 Dec; 7(49):81208-81222. PubMed ID: 27783991
[TBL] [Abstract][Full Text] [Related]
13. Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68.
Yu YA; Galanis C; Woo Y; Chen N; Zhang Q; Fong Y; Szalay AA
Mol Cancer Ther; 2009 Jan; 8(1):141-51. PubMed ID: 19139123
[TBL] [Abstract][Full Text] [Related]
14. Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy.
Rojas JJ; Sampath P; Hou W; Thorne SH
Clin Cancer Res; 2015 Dec; 21(24):5543-51. PubMed ID: 26187615
[TBL] [Abstract][Full Text] [Related]
15. Vaccinia virus GLV-1h237 carrying a Walker A motif mutation of mouse Cdc6 protein enhances human breast tumor therapy in mouse xenografts.
Hofmann E; Grummt F; Szalay AA
Int J Oncol; 2011 Mar; 38(3):871-8. PubMed ID: 21249314
[TBL] [Abstract][Full Text] [Related]
16. Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice.
Hofmann E; Weibel S; Szalay AA
J Transl Med; 2014 Jul; 12():197. PubMed ID: 25030093
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT).
Zuo S; Wei M; He B; Chen A; Wang S; Kong L; Zhang Y; Meng G; Xu T; Wu J; Yang F; Zhang H; Wang S; Guo C; Wu J; Dong J; Wei J
EBioMedicine; 2021 Feb; 64():103240. PubMed ID: 33581644
[TBL] [Abstract][Full Text] [Related]
18. An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy.
Yang Y; Xu W; Peng D; Wang H; Zhang X; Wang H; Xiao F; Zhu Y; Ji Y; Gulukota K; Helseth DL; Mangold KA; Sullivan M; Kaul K; Wang E; Prabhakar BS; Li J; Wu X; Wang L; Seth P
Hum Gene Ther; 2019 Sep; 30(9):1117-1132. PubMed ID: 31126191
[TBL] [Abstract][Full Text] [Related]
19. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
Chen NG; Yu YA; Zhang Q; Szalay AA
J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588
[TBL] [Abstract][Full Text] [Related]
20.
Giehl E; Kosaka H; Liu Z; Feist M; Kammula US; Lotze MT; Ma C; Guo ZS; Bartlett DL
Front Immunol; 2021; 12():610042. PubMed ID: 33679747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
